Scientific Diligence for Investors
Independent, science‑first diligence to inform term sheets and partnerships.
Mechanism & claims — biological plausibility, differentiation
Models & species — relevance, translatability, limitations
Study quality — design, controls, statistics, reproducibility
PK/PD & dose logic — target engagement, exposure margins
Safety signals — on/off‑target risks, mitigation options
Program plan — realism of timelines, budget, team/vendor dependencies
What we evaluate
Deliverable
Diligence memo with Red/Yellow/Green risk map
Partner Q&A pack
Scenario model
Do you join management calls?
Yes, to clarify assumptions and test claims.
Will you provide an opinion the value of the opportunity?
We provide science and execution risk input; financial valuation remains your process.
Confidentiality?
We operate under mutual NDA and conflict‑check across active engagements.